Downloads

1. From Discovery To Delivery: Accelerating The Path Forward For Gene Therapies 7/11/2025

   We caught up with Lexeo Therapeutics’ Manny Otero, Ph.D., and Sandi See Tai, MD, to explore strategies to advance gene therapies.

2. A Guide To Accelerating Cell Line Development For Commercial Production 7/11/2025

   Explore the challenges associated with cell line development in the production of biologics, and solutions that can help biotech developers evade the pitfalls of misinformed decision-making.

3. The Evolving Landscape Of Drug Discovery Services 7/11/2025

   Pharma and biotech companies are set to pursue partnerships with drug discovery service providers at an increased rate in the years ahead. And it’s not just small and emerging drug companies; it’s also Big Pharma.

4. TYK2 Inhibition Emerges As A Next-Gen Strategy To Treat PsA 7/10/2025

   The treatment landscape for psoriatic arthritis (PsA) is evolving rapidly, with data presented at EULAR 2025 signaling a new chapter in disease management with the emergence of a selective tyrosine kinase 2 (TYK2) inhibitor.

5. Multi-Indication Strategies Reshape Immunology's R&D Strategy 7/10/2025

   A clear trend at EULAR 2025 emerged across presentations and pipelines: leading biopharma players are increasingly embracing multi-indication strategies, designing assets to work across dermatology, rheumatology, and gastroenterology indications.

6. Immunology's Next Frontier: High-Risk, High-Reward Innovations From EULAR 2025 7/10/2025

   The 2025 European Congress of Rheumatology (EULAR) showcased a shift in immunology, highlighting a convergence of next-generation mechanisms and novel therapeutic modalities. Of note is the emergence of cell therapies as a treatment strategy.

7. Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development 7/9/2025

   Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

8. CRISPR Meets LNPs: A New Era In Cell And Gene Therapies 7/8/2025

   Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

9. New Regulatory Considerations For Animal Testing And The Consequences For Drug Product Formulation Development 7/3/2025

   The U.S. is experiencing a shift in the regulatory environment for animal testing, driven by the evolving use of AI. This impacts the formulation development approach for new drugs in the non-clinical phase. 

10. From Undruggable To Druggable: The Science Reshaping Small Molecule Discovery 7/1/2025

    For decades, most biologically validated disease-relevant protein targets have remained chemically inaccessible, thereby resisting conventional small molecule approaches. But now, a new wave of scientific innovation is paving a way forward.